Issues relating to lymphovascular invasion in breast carcinoma

Advances in Anatomic Pathology

Volumn 13, Issue 6, 2006, Pages 308-315

  Hoda, Syed A ^a,c   Hoda, Rana S ^b   Merlin, Scott ^a   Shamonki, Jamie ^a   Rivera, Michael ^a  

^a Department of Obstetrics Gynecology   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Breast; Breast carcinoma; Diagnosis; Lymphovascular invasion; Tumor emboli; Vascular invasion

Indexed keywords

APOCRINE CARCINOMA; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MELANOMA; METASTASIS; MUCINOUS CARCINOMA; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR EMBOLISM;

ADENOCARCINOMA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; NEOPLASM INVASIVENESS;

EID: 33750536633     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/01.pap.0000213048.69564.26     Document Type: Review

References (34)

1. Fisher ER, Anderson S, Tan-Chiu E, et al. Fifteen year prognostic discriminants for invasive breast carcinoma. NSABP Protocol-06. Cancer. 2001;91:1679-1688.
2. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the national Surgical Adjuvant Project for breast cancers (Protocol No. 4). X. Discriminants of tenth year treatment failure. Cancer. 1984;53:712-723.
3. Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg. 1999;230:692-696.
4. Lauria R, Perrone F, Carlomagno C, et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer. 1995;76:1772-1778.
5. Lee A, DeLellis RA, Silverman M, et al. Prrognostic significance of peritumoral lymphatic and blood-vessel invasion in node-negative carcinoma of the breast. J Clin Oncol. 1990;8:1457-1465.
6. Lee AKC, DeLellis RA, Silverman ML, et al. Lymphatic and blood vessel invasion in breast carcinoma. A useful prognostic indicator? Hum Pathol. 1986;17:984-987.
7. Locker AP. Factors influencing local recurrences after excision and radiotherapy for primary breast cancer. Br J Surg. 1989;76:890-894.
8. Nime FA, Rosen PP, Thaker HT, et al. Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol. 1977;1:25-30.
9. Pinder S, Ellis IO, O'Rorke S, et al. Pathological prognostic factors in breast cancer. Vascular invasion: relationship with recurrence and survival in a large series with long-term follow-up. Histopathol. 1994;24:41-47.
10. Rosen PP. Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance. Pathol Annu. 1983;18:215-232.
11. Schoppmann SF, Bayer G, Aumayr K, et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg. 2004;240:306-312.
12. Truong PT, Yong CM, Abnousi F, et al. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. J Am Coll Surg. 2005;200:912-921.
13. Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the predication of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol. 2001;8:145-149.
14. Woo CS, Silberman H, Nakamura SK, et al. Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast. Cancer. 2002;184:337-340.
15. TNM Atlas. Illustrated Guide to the TNM Classification of Malignant Tumours. In: Wittekind C, Sobin LH, Greene FL, et al, eds. New York: Wiley; 2005.
16. Hagensen CD. Diseases of the Breast. 3rd ed. New York: Saunders; 1986.
17. Gilchrist KW, Gould VE, Hirschl S, et al. Interobserver variation in the identification of breast carcinoma in intramammary lymphatics. Hum Pathol. 1982;13:170-172.
18. Rosen PP. Rosen's Breast Pathology. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2001.
19. Hanau CA, Machera H, Miettenen M. Immunohistochemical evaluation of vascular invasion in carcinomas with different markers. Appl Immunohistochem. 1993;1:46-50.
20. Saigo PE, Rosen PP. The application of immunohistochemical stains to identify endothelial-lined channels in mammary carcinoma. Cancer. 1975;59:51-54.
21. Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966-975.
22. Goldstein NS. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases? Am J Clin Pathol. 2002;118:425-434.
23. Gupta A, Deshpande CG, Badve S. Role of E-cadherins in development of lymphatic tumor emboli. Cancer. 2003;97:2341-2347.
24. Cowley GP, Smith ME. Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int J Cancer. 1995;60:325-329.
25. Nassar H. Carcinomas with micropapillary morphology: clinical significance and current concepts. Adv Anat Pathol. 2004;11:297-303.
26. Luna More S, de los Santos F, Breton JJ, et al. Estrogen and progesterone receptors, c-erbB-2, p53, and BCL-2 in 33 invasive micropapillary breast carcinomas. Pathol Res Pract. 1996;192:27-32.
27. Middleton LP, Tressera F, Sobel ME, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12:499-504.
28. Robbins GF, Shah J, Rosen P, et al. Inflammatory carcinoma of the breast. Surg Clin North Am. 1974;4:801-810.
29. Matsuo K, Fukotomi T, Tsuda H, et al. Apocrine carcinoma of the breast. Clinicopathological analysis and histological sub-classification of 12 cases. Breast Cancer. 1998;5:279-284.
30. Rosen PP. Axillary lymph node metastses in patients with occult non-invasive breast carcinoma. Cancer. 1980;46:1298-1306.
31. Carter BL, Jensen RA, Simpson JF, et al. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol. 2000;113:259-265.
32. Moore KH, Thaler HT, Tan LK, et al. Immunohistochemically detected tumor cells in the sentinel lymph nodes of the patients with breast carcinoma: biologic metastasis or procedural artifact? Cancer. 2004;100:929-934.
33. Diaz NM, Vrcel V, Centeno BA, et al. Modes of benign mechanical transport of breast epithelial cells to axillary lymph nodes. Adv Anat Pathol. 2005;12:7-9.
34. Sharkey FE, Addington SL, Fowler LJ, et al. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol. 1996;9:893-900.